Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers
Zijia Tao, Yiqiao Zhao, Xiaonan Chen
PeerJ (2020) Vol. 8, pp. e9589-e9589
Open Access | Times Cited: 21

Showing 21 citing articles:

The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I–Mediated Immune Response
Lei Zhang, Yuqing Li, Lingli Zhou, et al.
Cancer Research (2023) Vol. 83, Iss. 11, pp. 1834-1850
Open Access | Times Cited: 44
The RNA m6A writer METTL14 in cancers: Roles, structures, and applications
Huimin Zhou, Kai Yin, Yue Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188609-188609
Closed Access | Times Cited: 100
METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma
Lili Zhang, Xiaofang Luo, Sen Qiao
British Journal of Cancer (2022) Vol. 127, Iss. 1, pp. 30-42
Open Access | Times Cited: 32
Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer
Yang Li, Shimiao Zhu, Yutong Chen, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 18
METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression
Yongxi Zhang, Shuyuan Liu, Tiesuo Zhao, et al.
Oncology Reports (2021) Vol. 46, Iss. 2
Open Access | Times Cited: 39
Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets
Chen Da-hong, Jigang Zhang, Chuan-Xing Wu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 39
Novel insights into the m6A-RNA methyltransferase METTL3 in cancer
Yiqing Cai, Rui Feng, Tiange Lu, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 38
DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m 6 A modification and translation for cytoprotective autophagy in cervical cancer
Miaohua Zhu, Weiwei Shen, Qiming Wang, et al.
RNA Biology (2022) Vol. 19, Iss. 1, pp. 751-763
Open Access | Times Cited: 28
Post-transcriptional regulation of tumor suppressor gene lncRNA CARMN via m6A modification and miRNA regulation in cervical cancer
Bingjia Yu, Xiuting Li, Wenjing Yan, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 12, pp. 10307-10318
Closed Access | Times Cited: 11
Clinical and molecular significance of the RNA m6A methyltransferase complex in prostate cancer
Jennifer Lothion‐Roy, Daisy B. Haigh, Anna E. Harris, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 10
The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer
Ji Huang, Weimin Zhou, Chao Hao, et al.
PLoS Genetics (2022) Vol. 18, Iss. 10, pp. e1010366-e1010366
Open Access | Times Cited: 16
Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1
Jue Yang, Miaoxian Fang, Changjiang Yu, et al.
Annals of Translational Medicine (2023) Vol. 11, Iss. 10, pp. 350-350
Open Access | Times Cited: 8
LncNAP1L6 activates MMP pathway by stabilizing the m6A-modified NAP1L2 to promote malignant progression in prostate cancer
Yuxiao Zheng, Feng Qi, Lu Li, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 1, pp. 209-218
Open Access | Times Cited: 12
m6A Methylation Regulators Are Predictive Biomarkers for Tumour Metastasis in Prostate Cancer
Yingchun Liang, Xiaohua Zhang, Chenkai Ma, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4035-4035
Open Access | Times Cited: 10
Functions and mechanisms of N6‑methyladenosine in prostate cancer (Review)
Hongyuan Wan, Yanyan Feng, Jun‐Jie Wu, et al.
Molecular Medicine Reports (2022) Vol. 26, Iss. 3
Open Access | Times Cited: 3
The cellular uncertainty in thoracic aortic dissections: the roles of METTL3 and NOTCH1 on m6A in human aortic smooth muscle cells
Kelly Wright, Maryam Aboughdir, Amer Harky
Annals of Translational Medicine (2023) Vol. 11, Iss. 4, pp. 162-162
Open Access | Times Cited: 1
Interaction of the intestinal cytokines-JAKs-STAT3 and 5 axes with RNA N6-methyladenosine to promote chronic inflammation-induced colorectal cancer
Nardana Esmaeili, Ahmed Bakheet, William Tse, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Metabolic regulation in urological tumors: Interplay with epigenetics and epitranscriptomics
Vera Miranda‐Gonçalves, Catarina Guimarães‐Teixeira, Rui Henrique, et al.
Elsevier eBooks (2021), pp. 107-145
Closed Access | Times Cited: 1
METTL3 promotes PGC-1α transcription and alleviates mitochrondrial dysfunction of diabetic nephropathy by targeting lncRNA TUG1 m6A modification
Tong Chen, Juan Wang, Yanyan Xu, et al.
Authorea (Authorea) (2023)
Open Access
METTL3 promotes PGC-1α transcription and alleviates mitochrondrial dysfunction of diabetic nephropathy by targeting lncRNA TUG1 m6A modification
Tong Chen, Juan Wang, Yanyan Xu, et al.
Research Square (Research Square) (2023)
Open Access
Effects of curcumin on Wnt/β-catenin, Hedgehog pathways and expression of EMT transcription factors in basal conditions and upon HIF1A and RELA knockdown in HeLa cells
Victor Chmykhalo, Anna A. Belanova, Tatyana Shkurat, et al.
Gene Reports (2023) Vol. 33, pp. 101848-101848
Closed Access
Page 1

Scroll to top